Status:
COMPLETED
Ultrasound Evaluation of Carotid Artery Atherosclerotic Plaques and Recanalization
Lead Sponsor:
Xuanwu Hospital, Beijing
Collaborating Sponsors:
The First Affiliated Hospital of Soochow University
The First Hospital of Jilin University
Conditions:
Stroke
Eligibility:
All Genders
18-85 years
Brief Summary
The purpose of this multiple-center study are: 1) To establish the ultrasound criteria for evaluating vulnerable plaques by comparing the plaque echo characteristics before CEA (carotid artery endarte...
Detailed Description
In this study, a total of 1000-1200 patients with carotid artery moderate (50-69%, with symptoms), severe (70-99%) stenosis (with or without symptoms) or occlusion who received either CEA or stenting ...
Eligibility Criteria
Inclusion
- 1\) Patients with carotid artery moderate (50-69%, with symptoms), severe (70-99%, with or without symptoms) stenosis or occlusion diagnosed by CDFI and confirmed by CTA or DSA.
- 2\) Patient has the indications for carotid artery stenting or CEA according to the guidelines published by the Stroke Prevention Engineering Committee, the National Health Commission of China.
- 3\) Patient with complete imaging evaluation and can be followed up to at least 1 year.
Exclusion
- \- 1) Patients with non-atherosclerotic carotid artery stenosis or occlusion, such as dissection, aneurysm, arteritis, cardiac embolism and et al.
- 2\) Patients with cerebral hemorrhage. 3) Pregnant
Key Trial Info
Start Date :
May 16 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2020
Estimated Enrollment :
1213 Patients enrolled
Trial Details
Trial ID
NCT03786666
Start Date
May 16 2019
End Date
December 30 2020
Last Update
March 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xuanwu Hospital, Capital Medical University
Beijing, Beijing Municipality, China, 100053